Seed Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Seed Therapeutics?

Seed Therapeutics is funded by Eisai.

Q: When was the last funding round for Seed Therapeutics?

Seed Therapeutics closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Seed Therapeutics raised to date?

Seed Therapeutics has raised obfuscated.

Overview

Seed Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Seed Therapeutics

CB Rank

26553

Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.

Founded

obfuscation

Private

Series A

King Of Prussia, Pennsylvania, United States

11-50

www.seedtherapeutics.com

Biotechnology

Medical

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Key People

Lan Huang: Founder and CEO
Bill Desmarais: Chief Financial Officer and Chief Business Officer
Past Role: Alchemab Therapeutics, Chief Business Officer

Details

Legal Name

Seed Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Phone Number

1-646-859-2751

Contact Email

info@seedtherapeutics.com

Predictions & Insights

Growth Insight

See this Growth Insight

Seed Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

RITE3™ TPD Platform

A proprietary platform for discovering molecular glue and bifunctional degraders that induce targeted protein degradation of disease-causing proteins.

ST-01156 Molecular Glue

An oral molecular glue degrader targeting RBM39, an RNA splicing factor implicated in multiple solid tumor cancers, advancing toward clinical trials.

Research & Development

Seed Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Seed Therapeutics	1	obfuscated obfuscation	Eisai	Series A
obfuscated obfuscation	Series A - Seed Therapeutics	1	obfuscated obfuscation	Eisai	Series A
obfuscated obfuscation	Series A - Seed Therapeutics	1	obfuscated obfuscation	Eisai	Series A
obfuscated obfuscation	Series A - Seed Therapeutics	1	obfuscated obfuscation	Eisai	Series A
obfuscated obfuscation	Series A - Seed Therapeutics	1	obfuscated obfuscation	Eisai	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Seed Therapeutics	1	obfuscated obfuscation	Eisai	Series A
obfuscated obfuscation	Series A - Seed Therapeutics	1	obfuscated obfuscation	Eisai	Series A
obfuscated obfuscation	Series A - Seed Therapeutics	1	obfuscated obfuscation	Eisai	Series A
obfuscated obfuscation	Series A - Seed Therapeutics	1	obfuscated obfuscation	Eisai	Series A
obfuscated obfuscation	Series A - Seed Therapeutics	1	obfuscated obfuscation	Eisai	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Eisai	Yes	Series A - Seed Therapeutics	—
Eisai	Yes	Series A - Seed Therapeutics	—
Eisai	Yes	Series A - Seed Therapeutics	—
Eisai	Yes	Series A - Seed Therapeutics	—
Eisai	Yes	Series A - Seed Therapeutics	—